This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: December 8, 2023
Source: https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html
Reason: Acquired by Amgen
Last recorded trade on: December 8, 2023
Source: https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html
Horizon Therapeutics
HZNP
105,67 €
Share price
0.00%
Change (1 day)
4.07%
Change (1 year)
Categories
Horizon Therapeutics (HZNP) - Cash on Hand
Cash on Hand as of June 2023 : €2.23 Billion
According to Horizon Therapeutics
's latest financial reports the company has €2.23 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Horizon Therapeutics - Cash on Hand chart (from 2009 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | €2.19 B | 57.19% |
| 2021-12-31 | €1.39 B | -17.48% |
| 2020-12-31 | €1.69 B | 76% |
| 2019-12-31 | €0.96 B | 14.65% |
| 2018-12-31 | €0.83 B | 33.83% |
| 2017-12-31 | €0.62 B | 29.39% |
| 2016-12-31 | €0.48 B | -38.44% |
| 2015-12-31 | €0.78 B | 336.99% |
| 2014-12-31 | €0.17 B | 208.72% |
| 2013-12-31 | €58.27 M | -25.94% |
| 2012-12-31 | €78.68 M | 468.79% |
| 2011-12-31 | €13.83 M | 241.78% |
| 2010-12-31 | €4.04 M | -19.01% |
| 2009-12-31 | €4.99 M | -50.33% |
| 2008-12-31 | €10.06 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | €10.87 B | 385.79% | 🇺🇸 USA |
 | €5.13 B | 129.41% | 🇬🇧 UK |
 | €18.60 B | 730.84% | 🇺🇸 USA |
 | €0.62 B | -72.01% | 🇮🇳 India |
 | €12.43 B | 455.42% | 🇺🇸 USA |